These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2123036)

  • 41. Effect of 4-aminopyrazolo[3,4-d]pyrimidine on the catabolism of high-density lipoprotein apolipoprotein A-I in the rat.
    van 't Hooft FM; van Tol A
    Biochim Biophys Acta; 1986 Apr; 876(2):333-9. PubMed ID: 3082368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atherogenicity of blood serum from patients with coronary heart disease.
    Chazov EI; Tertov VV; Orekhov AN; Lyakishev AA; Perova NV; Kurdanov KA; Khashimov KA; Novikov ID; Smirnov VN
    Lancet; 1986 Sep; 2(8507):595-8. PubMed ID: 2875319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of two monoclonal antibodies to human apolipoprotein A-I that also bind to rabbit apolipoprotein A-I. Application to ELISA evaluation of rabbit serum apo A-I.
    Leroy A; Olivier P; Vu-Dac N; Fruchart JC
    Clin Chim Acta; 1989 Jan; 179(1):85-95. PubMed ID: 2493349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High density lipoproteins and prevention of experimental atherosclerosis with special reference to tree shrews.
    She MP; Xia RY; Ran BF; Wong ZL
    Ann N Y Acad Sci; 1990; 598():339-51. PubMed ID: 2123379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The inhibitory effect of apolipoproteins in HDL on experimental atherosclerosis in rabbits].
    Ran BF
    Zhonghua Bing Li Xue Za Zhi; 1989 Dec; 18(4):257-61. PubMed ID: 2636953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of high density lipoprotein (HDL), prepared from human blood, on prostanoid formation, serum and tissue lipids and development of arteriosclerosis in cholesterol rich fed rabbits.
    Beitz J; Kuklinski B; Beitz A; Taube C; Oswald B; Szymanski C; Rath FW; Mest HJ
    Prostaglandins Leukot Essent Fatty Acids; 1990 Jul; 40(3):211-5. PubMed ID: 2402525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies of lipoprotein (a) and high density lipoproteins in transgenic mice.
    Rubin EM
    Atherosclerosis; 1994 Oct; 110 Suppl():S77-81. PubMed ID: 7857389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipids, lipoproteins and apolipoprotein (a) isoforms in type 2 diabetic patients.
    Calmarza P; Vella JC
    J Cardiovasc Risk; 1999 Jun; 6(3):171-5. PubMed ID: 10463144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic but not diet-induced hypercholesterolemia causes low apolipoprotein A-IV level in rabbit sera.
    Mezdour H; Yamamura T; Nomura S; Yamamoto A
    Atherosclerosis; 1995 Mar; 113(2):171-8. PubMed ID: 7605356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipoprotein(a) in diet-induced atherosclerosis in nonhuman primates.
    Nachman RL; Gavish D; Azrolan N; Clarkson TB
    Arterioscler Thromb; 1991; 11(1):32-8. PubMed ID: 1824815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of cholesterol dosage, cortisone, and DCA on total serum cholesterol, lipoproteins, and atherosclerosis in the rabbit.
    COOK DL; RAY G; DAVISSON E; FELDSTEIN LM; CALVIN LD; GREEN DM
    J Exp Med; 1952 Jul; 96(1):27-34. PubMed ID: 14946326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of acarbose (a glucosidase inhibitor) on experimental atherosclerosis in the rabbit.
    Kritchevsky D; Tepper SA; Davidson LM; Klurfeld DM
    Artery; 1990; 17(3):170-5. PubMed ID: 2186716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discrepancies in the catabolic pathways of human and rat high-density lipoprotein apolipoprotein A-I in the rat.
    van't Hooft FM; van Tol A
    Eur J Clin Invest; 1985 Dec; 15(6):395-402. PubMed ID: 3938410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is dietary ergotamine atherogenic in the rabbit?
    Meijer GW; Janssen GB; Beynen AC; Speijers GJ
    Food Chem Toxicol; 1992 Aug; 30(8):731-4. PubMed ID: 1398355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dyslipoproteinemia and other risk factors for atherosclerosis in children and adolescents.
    Kwiterovich PO
    Atherosclerosis; 1994 Aug; 108 Suppl():S55-71. PubMed ID: 7802729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo interaction of synthetic acylated apopeptides with high density lipoproteins in rat.
    Ponsin G; Sparrow JT; Gotto AM; Pownall HJ
    J Clin Invest; 1986 Feb; 77(2):559-67. PubMed ID: 3080478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese.
    Woo J; Lau E; Lam CW; Kay R; Teoh R; Wong HY; Prall WY; Kreel L; Nicholls MG
    Stroke; 1991 Feb; 22(2):203-8. PubMed ID: 1825896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipoprotein immunogenetics and atherosclerosis.
    Rapacz J
    Am J Med Genet; 1978; 1(4):377-405. PubMed ID: 96696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid markers for atherosclerosis.
    Kottke BA
    Am J Cardiol; 1986 Feb; 57(5):11C-17C. PubMed ID: 3080862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clearance effect of 3H-cholesterol by Apo-AI/DPPC liposome from cultured SMC of rabbits and tree shrew].
    Cai CB
    Zhonghua Bing Li Xue Za Zhi; 1990 Mar; 19(1):12-5. PubMed ID: 2116940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.